(Q33721228)

28 July 2017

Study of urinary proteomes in Anderson-Fabry disease (English)

1 reference

28 July 2017

1 reference

2

Tomáš Zima

1 reference

28 July 2017

3

Vladimír Tesař

1 reference

28 July 2017

Lucie Vojtová

1

1 reference

28 July 2017

Jana Michalová

4

1 reference

28 July 2017

Petr Přikryl

5

1 reference

28 July 2017

Gabriela Dostálová

6

1 reference

28 July 2017

Aleš Linhart

7

1 reference

28 July 2017

1 January 2010

1 reference

28 July 2017

1 reference

28 July 2017

32

1 reference

28 July 2017

10

1 reference

28 July 2017

1202-1209

1 reference

Fabry disease: overall effects of agalsidase alfa treatment

28 July 2017

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

The heart in Anderson-Fabry disease and other lysosomal storage disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

High incidence of later-onset fabry disease revealed by newborn screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

Elevated globotriaosylsphingosine is a hallmark of Fabry disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

Biomarkers of Fabry disease nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

Development of an effective sample preparation method for the proteome analysis of body fluids using 2-D gel electrophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

Urinary excretions of lipocalin-type prostaglandin D2 synthase predict the development of proteinuria and renal injury in OLETF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

Properties of the glomerular barrier and mechanisms of proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

Combined proteomic and metabonomic studies in three genetic forms of the renal Fanconi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

New insights in cardiac structural changes in patients with Fabry’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

Pathobiochemistry of nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

Recent Progress in the Pathogenesis of Nephrotic Proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.516859

10.3109/0886022X.2010.516859

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference